Association between Pneumonia Development and Virulence Gene Expression in Carbapenem-Resistant Acinetobacter baumannii Isolated from Clinical Specimens
Table 3
Expression levels of Acinetobacter baumannii virulence genes and clinical characteristics of deceased and surviving patients.
Deceased (n = 10)
Survived (n = 31)
Age, median (IQR), y
77 (71–82)
66 (58–78)
0.10
Female sex, no. (%)
3 (30.0)
6 (19.4)
0.66
Charlson score, median (IQR)
5 (4–7)
4 (2–7)
0.26
ICU stay, no. (%)
9 (90.0)
20 (64.5)
0.23
Mechanical ventilation, no. (%)
6 (60.0)
13 (41.9)
0.47
ompA, median (IQR)
1.97 (0.74–2.85)
0.86 (0.15–1.40)
0.02
hisF, median (IQR)
1.06 (0.90–1.21)
0.10 (0.08–0.86)
<0.01
uspA, median (IQR)
1.62 (1.16–1.75)
1.01 (0.64–1.21)
<0.01
hfq, median (IQR)
1.54 (1.39–1.74)
1.31 (1.13–2.00)
0.19
feoA, median (IQR)
1.61 (1.09–1.84)
1.20 (0.84–1.66)
0.15
bfnL, median (IQR)
3.14 (2.42–3.86)
2.14 (1.75–2.53)
0.03
IQR, interquartile range; ICU, intensive care unit.
